AU681618B2 - Ointment for wound treatment - Google Patents

Ointment for wound treatment Download PDF

Info

Publication number
AU681618B2
AU681618B2 AU57945/94A AU5794594A AU681618B2 AU 681618 B2 AU681618 B2 AU 681618B2 AU 57945/94 A AU57945/94 A AU 57945/94A AU 5794594 A AU5794594 A AU 5794594A AU 681618 B2 AU681618 B2 AU 681618B2
Authority
AU
Australia
Prior art keywords
weight
gel
hexylene glycol
composition according
glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57945/94A
Other languages
English (en)
Other versions
AU5794594A (en
Inventor
Craig J. Hardy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Systagenix Wound Management IP Co BV
Original Assignee
Johnson and Johnson Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Inc filed Critical Johnson and Johnson Medical Inc
Publication of AU5794594A publication Critical patent/AU5794594A/en
Application granted granted Critical
Publication of AU681618B2 publication Critical patent/AU681618B2/en
Assigned to SYSTAGENIX WOUND MANAGEMENT IP CO. B.V. reassignment SYSTAGENIX WOUND MANAGEMENT IP CO. B.V. Assignment by Patentee under S 187, Reg 19.1 Assignors: JOHNSON & JOHNSON MEDICAL, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0071—Plasticisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
AU57945/94A 1993-03-23 1994-03-21 Ointment for wound treatment Ceased AU681618B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9306039 1993-03-23
GB9306039A GB2276819B (en) 1993-03-23 1993-03-23 Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol

Publications (2)

Publication Number Publication Date
AU5794594A AU5794594A (en) 1994-09-29
AU681618B2 true AU681618B2 (en) 1997-09-04

Family

ID=10732613

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57945/94A Ceased AU681618B2 (en) 1993-03-23 1994-03-21 Ointment for wound treatment

Country Status (12)

Country Link
US (2) US5723144A (enExample)
EP (1) EP0621031B1 (enExample)
JP (1) JP2763492B2 (enExample)
AT (1) ATE182072T1 (enExample)
AU (1) AU681618B2 (enExample)
BR (1) BR9401241A (enExample)
CA (1) CA2119516C (enExample)
DE (1) DE69419447T2 (enExample)
ES (1) ES2135541T3 (enExample)
GB (1) GB2276819B (enExample)
IN (1) IN177229B (enExample)
ZA (1) ZA941827B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670169A (en) * 1993-12-20 1997-09-23 E.R. Squibb & Sons, Inc. Wound hydrating gel with novel preservative system and low cytotoxicity
GB2291348B (en) * 1994-07-18 1999-01-20 Johnson & Johnson Medical Sterile gel composition for wound treatment comprising alginate and polyhydric alcohol
EP0987019A1 (en) * 1998-09-01 2000-03-22 Virotex Corporation Topical antibiotic composition for rapid wound healing
GB9618570D0 (en) * 1996-09-05 1996-10-16 Courtaulds Fibres Holdings Ltd Improvements in or relating to wound dressings
GB9618573D0 (en) * 1996-09-05 1996-10-16 Courtaulds Fibres Holdings Ltd Wound dressings and manufacture thereof
RU2141818C1 (ru) * 1997-03-27 1999-11-27 Седов Валерий Николаевич Паста для лечения трофических язв и длительно незаживающих ран
RU2148989C1 (ru) * 1998-06-09 2000-05-20 Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра РАН Препарат для лечения длительно не заживающих ран и трофических язв (варианты)
WO2000028978A1 (en) * 1998-11-18 2000-05-25 Medical Industries Corp. Agents for repairing damaged tissue sites
JP4558208B2 (ja) * 1998-11-24 2010-10-06 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 吸収包帯と包帯上の活性成分の分配器として有効なコーティング
US6046160A (en) * 1999-07-22 2000-04-04 Deroyal Industries, Inc. Composition and method for enhancing wound healing
CA2390556C (en) 1999-11-09 2009-05-19 Denki Kagaku Kogyo Kabushiki Kaisha Use of soluble cellulose derivative having been made hardly soluble in water and method for producing it
US20070009586A1 (en) * 2000-02-29 2007-01-11 Cohen Kelman I Wound dressings containing complexes of transition metals and alginate for elastase sequestering
US20040001878A1 (en) * 2002-06-26 2004-01-01 Deroyal Industries, Inc. Infused wound care dressings
US20070004672A1 (en) * 2005-07-01 2007-01-04 Dharmendra Jani Long lasting alginate dry eye, related methods of manufacture and methods of use
DE102005060461A1 (de) 2005-12-17 2007-07-12 Paul Hartmann Ag Medizinische Zusammensetzung
EP2296637B1 (en) * 2008-04-24 2014-04-02 Medtronic, Inc Chitosan-containing protective composition
EP2288389B1 (en) * 2008-04-24 2014-06-11 Medtronic, Inc Cold ionizing radiation sterilization
EP2310002B1 (en) * 2008-04-24 2016-11-02 Medtronic, Inc Protective gel based on chitosan and oxidized polysaccharide
US20090269417A1 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Thiolated chitosan gel
US9198997B2 (en) 2008-04-24 2015-12-01 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
JP5582711B2 (ja) * 2008-09-25 2014-09-03 株式会社エー・アイ・システムプロダクト ローション状の塗薬
MD4197C1 (ro) * 2012-10-22 2013-09-30 Мария ДАНУ Metodă de tratament al ulcerelor trofice
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
MX2017004520A (es) 2014-10-14 2018-03-15 Lynch Samuel Composiciones para tratar heridas.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1603683A (en) * 1982-06-24 1984-01-26 Chiltern Pharmaceuticals Pty. Limited Pharmaceutical gel composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
FR2489145A1 (fr) * 1980-09-04 1982-03-05 Geistlich Soehne Ag Compositions pharmaceutiques accelerant la guerison de blessures
JPS57142913A (en) * 1981-02-27 1982-09-03 Nitto Electric Ind Co Ltd Donor of physiologically active substance
JPS58174484A (ja) * 1982-04-08 1983-10-13 Kao Corp 感圧性粘着テ−プ又はシ−ト
US4604384A (en) * 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
FR2532546B1 (fr) * 1982-09-07 1985-12-27 Biotrol Sa Lab Pate pour la protection de la peau
US4643856A (en) * 1985-03-21 1987-02-17 Moleculon, Inc. Process of making gelled cellulose triacetate product
US4666671A (en) * 1985-04-03 1987-05-19 Givaudan Corporation Method for deodorizing urinals and toilet bowls with fragranced gel blocks
JPS62123112A (ja) * 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
GB8818114D0 (en) * 1988-07-29 1988-09-01 Johnson & Johnson Haemostatic wound dressing material
US5084427A (en) * 1990-10-22 1992-01-28 Uop Aqueous suspensions of aluminosilicate molecular sieves
US5385729A (en) * 1991-08-01 1995-01-31 Colgate Palmolive Company Viscoelastic personal care composition
JP3254013B2 (ja) * 1991-09-10 2002-02-04 ジョンソン・アンド・ジョンソン・メディカル・インコーポレイテッド 包帯材料およびその製造方法
GB9208731D0 (en) * 1992-04-22 1992-06-10 Squibb & Sons Inc Hydrocolloid wound gel
US5470576A (en) * 1992-06-08 1995-11-28 The Kendall Company Process for preparing the alginate-containing wound dressing
US5338541A (en) * 1992-10-15 1994-08-16 Calgon Corporation Dual cationic terpolymers providing superior conditioning properties in hair, skin and nail care products

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1603683A (en) * 1982-06-24 1984-01-26 Chiltern Pharmaceuticals Pty. Limited Pharmaceutical gel composition

Also Published As

Publication number Publication date
GB9306039D0 (en) 1993-05-12
GB2276819B (en) 1996-12-11
CA2119516C (en) 2005-09-06
US5723144A (en) 1998-03-03
ZA941827B (en) 1995-09-15
JP2763492B2 (ja) 1998-06-11
GB2276819A (en) 1994-10-12
ES2135541T3 (es) 1999-11-01
IN177229B (enExample) 1996-12-07
US5688522A (en) 1997-11-18
EP0621031B1 (en) 1999-07-14
EP0621031A2 (en) 1994-10-26
JPH07109220A (ja) 1995-04-25
ATE182072T1 (de) 1999-07-15
DE69419447T2 (de) 2000-01-05
AU5794594A (en) 1994-09-29
EP0621031A3 (en) 1995-04-19
BR9401241A (pt) 1994-11-08
CA2119516A1 (en) 1994-09-24
DE69419447D1 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
US5688522A (en) Ointment for wound treatment
JP7054212B2 (ja) 有効な創傷ケア処置としての新規高速付着薄膜形成組成物
DE60028978T2 (de) Ophthalmische zusammensetzung enthaltend antibiotika und nsaids
EP0480189B1 (en) Pharmaceutical compositions for topical use comprising hyaluronic acid sodium salt and disinfectant substances
US6348190B1 (en) Pharmaceutical compositions with antimicrobial activity
DE69629519T2 (de) Stable Komplexen von vernetzten Polyvinylpyrrolidone und Iod und Verfahren zur Herstellung
LV12951B (en) Gel for treatment of skin diseases and for disinfection of the skin
DE69434992T2 (de) Hyaluronsäure und deren derivate enthaltende arzneimittel zur topischen anwendung
US6521243B2 (en) Ionic chitosan -iodine complexes: antiseptic hydrogels and wound healing promoters
DE69414521T2 (de) Verfahren zur herstellung von iodierten biopolymeren mit desinfizierender und vernarbungsfördernder wirkung und darnach hergestellte iodierte biopolymeren
DE60319221T2 (de) Quaternisierte ammoniumcyclodextrinverbindungen
US12171779B2 (en) Regulated drug delivery via controlled degradable chondroitin sulfate particles
EP1128809A1 (en) Aqueous ophthalmic formulations comprising chitosan
CA1333566C (en) Pharmaceutical and/or cosmetic composition for local use containing rhamsan gum
US3944668A (en) Antimicrobial compositions
DE3500755C2 (enExample)
CN112438964A (zh) 一种溶葡萄球菌酶与壳聚糖复合抗菌喷膜剂
US4038388A (en) Antimicrobial compositions
DE60214889T2 (de) Sucroseoctasulphat silber saltz
JP3054758B2 (ja) 外傷用組成物
US4897404A (en) Anti-infective methods and compositions
CN111603440A (zh) 一种妇科凝胶泡沫剂及其制备方法
US4895857A (en) Anti-infective methods and compositions
DE102020101110A1 (de) Antimykotische Aktivitäten von Hydrogelen auf Basis von Polysacchariden
CN110787126A (zh) 一种盐酸莫西沙星眼用凝胶及其制备方法